Secretory production system of bionanocapsules using a stably transfected insect cell line

[1]  Akihiko Kondo,et al.  The specific delivery of proteins to human liver cells by engineered bio‐nanocapsules , 2005, The FEBS journal.

[2]  A. El-Aneed,et al.  An overview of current delivery systems in cancer gene therapy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[3]  A. Kondo,et al.  Nanoparticles for the delivery of genes and drugs to human hepatocytes , 2003, Nature Biotechnology.

[4]  A. Hirko,et al.  Cationic lipid vectors for plasmid DNA delivery. , 2003, Current medicinal chemistry.

[5]  G. Webersinke,et al.  Overexpression of hepatitis B virus surface antigens including the preS1 region in a serum-free Chinese hamster ovary cell line. , 2003, Protein expression and purification.

[6]  H. Herweijer,et al.  Progress and prospects: naked DNA gene transfer and therapy , 2003, Gene Therapy.

[7]  C. von Kalle,et al.  Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. , 2003, Blood.

[8]  I. Schmidt-Wolf,et al.  Non-viral and hybrid vectors in human gene therapy: an update. , 2003, Trends in molecular medicine.

[9]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[10]  C. von Kalle,et al.  Murine Leukemia Induced by Retroviral Gene Marking , 2002, Science.

[11]  A. Kondo,et al.  Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein. , 2001, Vaccine.

[12]  C. Arntzen,et al.  Production of hepatitis B surface antigen in transgenic plants for oral immunization , 2000, Nature Biotechnology.

[13]  H. Grosshans.  Gene therapy – when a simple concept meets a complex reality , 2000, Functional & Integrative Genomics.

[14]  R. Wagner,et al.  Purification and characterization of hepatitis B virus surface antigen particles produced in Drosophila Schneider-2 cells. , 1999, Journal of virological methods.

[15]  R. Wagner,et al.  High level expression of hepatitis B virus surface antigen in stably transfected Drosophila Schneider-2 cells. , 1999, Journal of virological methods.

[16]  T. Tadakuma,et al.  Cell‐specific expression of the diphtheria toxin A‐chain coding sequence under the control of the upstream region of the human alpha‐fetoprotein gene , 1999, Journal of surgical oncology.

[17]  K. Iatrou,et al.  High-level expression of secreted glycoproteins in transformed lepidopteran insect cells using a novel expression vector. , 1998, Biotechnology and bioengineering.

[18]  K. Iatrou,et al.  A Baculovirus (Bombyx mori Nuclear Polyhedrosis Virus) Repeat Element Functions as a Powerful Constitutive Enhancer in Transfected Insect Cells* , 1997, The Journal of Biological Chemistry.

[19]  K. Iatrou,et al.  Trans-activation of a cell housekeeping gene promoter by the IE1 gene product of baculoviruses. , 1996, Virology.

[20]  S. Kuroda,et al.  Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. , 1992, The Journal of biological chemistry.

[21]  R. Kennedy,et al.  Expression and characterization of hepatitis B virus surface antigen polypeptides in insect cells with a baculovirus expression system , 1989, Journal of virology.

[22]  W. Gerlich,et al.  Large surface proteins of hepatitis B virus containing the pre-s sequence , 1984, Journal of virology.

[23]  B D Hall,et al.  Synthesis and assembly of hepatitis B virus surface antigen particles in yeast , 1982, Nature.

[24]  K. Iatrou,et al.  Screening of Transformed Insect Cell Lines for Recombinant Protein Production , 1999, Biotechnology progress.

[25]  P. Schlag,et al.  Hepatocyte-specific binding of L/S-HBV particles expressed in insect cells. , 1995, Biological chemistry Hoppe-Seyler.